1. Home
  2. PKE vs ALT Comparison

PKE vs ALT Comparison

Compare PKE & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$30.39

Market Cap

463.2M

Sector

Industrials

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$3.37

Market Cap

415.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
ALT
Founded
1954
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
463.2M
415.3M
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
PKE
ALT
Price
$30.39
$3.37
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.67
AVG Volume (30 Days)
235.6K
2.8M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
1.69%
N/A
EPS Growth
N/A
25.37
EPS
0.37
N/A
Revenue
N/A
$41,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$79.76
N/A
Revenue Growth
N/A
105.00
52 Week Low
$12.41
$2.87
52 Week High
$29.85
$7.73

Technical Indicators

Market Signals
Indicator
PKE
ALT
Relative Strength Index (RSI) 65.03 44.78
Support Level $17.99 $2.89
Resistance Level N/A $4.25
Average True Range (ATR) 1.30 0.18
MACD 0.16 0.06
Stochastic Oscillator 82.55 76.12

Price Performance

Historical Comparison
PKE
ALT

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: